ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

ConclusionsThe results of the current study suggest that real-world symptom data collected through the ePRO application on cancer patients receiving ICI therapy aligns with the data from clinical trials. Correlations between different symptoms occur, which might reflect therapeutic efficiency, side effects, or tumor progression. These correlations should be further investigated with data coupled to clinical outcomes.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research